AbbVie to discontinue phase 1 trial for I-Mab’s anti-CD47 therapy for treatment of cancers Posted on August 16, 2022 By Charlielikes Stock Market Tags:‘to, $1, abbvie,, anti-cd47, cancers, discontinue, for, i-mab’s, market, of, phase, stock, stock market, therapy, treatment, trial